Rose Pharma

Rose Pharma is focused on the development of novel treatments for IBS and anorexia/cachexia associated with cancer and other major pathologies. Rose’s lead molecule is an NCE analogue of GLP-1 in Phase II development.


Enda Kenny
Sub segment
Copenhagen, Denmark

Related companies

Leave a Comment

Your email address will not be published. Required fields are marked *